Xenetic Biosciences, Inc.
XBIO· Nasdaq
Filed Apr 15, 2015 · 10-K · 105 days after period end · 0001019687-15-001465
derived · Computed from the longer spans the company filed.
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|
| Revenue | — | $0.00 |
| Net Income | -$4.30M | -$3.54M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Apr 15, 2015 · 105 d after period end